SNP rs11185644 in RXRA gene and SNP rs2235544 in DIO1 gene predict dosage requirements in a cross-sectional sample of hypothyroid patients

BMC Endocrine Disorders

Research

Suzan Al-Wawi¹  Rowan AlEjielat¹  Anas Khaleel¹  Yazan S. Batarseh¹  Luay Abu-Qatouseh¹  Toleen AlSunna² 

[1] Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan;Independent researcher, Amman, Jordan;

关键词: Levothyroxine;    SNP;    Hypothyroid;    Dose;    Pharmacogenomics;    Personalized medicine;   

DOI  :  10.1186/s12902-023-01425-z

 received in 2023-01-17, accepted in 2023-07-27,  发布年份 2023

来源: Springer

【 摘 要 】

Background and purposePrimary hypothyroidism due to abnormality in the thyroid gland is the most common endocrine disease The recommended starting dose of levothyroxine replacement therapy is 1.6 µg/kg. This dose however is not optimal for every patient and dose adjustments are frequently done. Genetic polymorphisms in the absorption and metabolism pathway of levothyroxine are likely to influence its dose requirements. This study aimed to study the influence of genetic polymorphisms on levothyroxine replacement requirements.MethodsThis was a cross-sectional study. Participants were recruited through a private nutrition clinic and through announcements distributed in the University of Petra in Amman, Jordan between September 2020 and February 2021. Hypothyroid patients had already been on stable doses of levothyroxine for the previous 3 months. A questionnaire was distributed to collect demographic and clinical information and a blood sample was taken for DNA extraction and clinical biochemistry analysis. rs11249460, rs2235544, rs225014, rs225015, rs3806596, rs11185644, rs4588, rs602662 were analyzed using Applied Biosystems TaqMan™ SNP Genotyping Assays on Rotor-Gene® Q and rs3064744 by direct sequencing. SPSS and Excel were used to perform analysis.Results76 patients were studied. The equation we calculated to find predicted daily dose of levothyroxine (mcg/kg) is 3.22+ (0.348 for CT genotype of rs11185644, 0 for other genotypes) + 0.027*disease duration (years) − 0.014*age (years) − 0.434*T3 (pmol/L) levels+ (0.296 for CC genotype of rs2235544, 0 for other genotypes).ConclusionSNP rs11185644 in RXRA gene and SNP rs2235544 in DIO1 affect dose requirement in hypothyroid patients and if confirmed in larger trials they can be used to individualize thyroxine starting doses.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023